Presentation TCT 2022 Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial Presenter: Christos Rammos September 17, 2022
Presentation TCT 2022 Have We Gotten to the Final Word on Paclitaxel Safety? Presenter: Eric Secemsky September 17, 2022
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022